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Purpose: To identify the underlying genetic defect in four generations of a Chinese family affected with bilateral
congenital posterior subcapsular cataracts.
Methods: Clinical data from patients in the family were recorded by slit-lamp photography. Genomic DNA samples were
extracted from peripheral blood of the pedigree members. Mutation screening was performed in the candidate gene by
bidirectional  sequencing  of  the  amplified  products.  The  mutation  was  verified  by  restriction  fragment  length
polymorphism (RFLP) analysis.
Results:  The  congenital  cataract  phenotype  of  the  pedigree  was  identified  as  posterior  subcapsular  by  slit-lamp
photography. Sequencing of the candidate genes detected a heterozygous c.5C→T change in the coding region of the
βB2-crystallin gene (CRYBB2), resulting in the substitution of a highly conserved alanine to valine (p. A2V). All nine
family members affected with cataracts were positive for this change, but it was not observed in any of the unaffected
members of the family. The transition resulted in the loss of a HaeIII restriction site in the affected members of the pedigree,
which was present in the unaffected family members and in all of the 100 unrelated individuals tested.
Conclusions: This study has identified a novel CRYBB2 gene mutation, resulting in the amino substitution p. A2V in a
Chinese family with posterior subcapsular congenital cataracts. This mutation is probably the causative lesion for the
observed phenotype in this family.
Congenital cataracts, the loss of eye lens transparency,
are  a  leading  cause  of  visual  impairment  or  blindness  in
childhood.  Depending  on  regional  socioeconomic
development, its prevalence varies from 1−6 cases per 10,000
live births in industrialized countries [1,2] to 5−15 per 10,000
in the poorest areas of the world [3,4]. Globally, congenital
cataracts account for approximately one-tenth of childhood
blindness due to different causes including infections during
embryogenesis, metabolic disorders (galactosemia), and gene
defects [5]. As inherited cataracts correspond to 8−25% of
congenital cataracts [6], genetic mutation is likely the most
common cause. Although autosomal recessive and X-linked
forms of inheritance also exist, autosomal dominance is the
major  form  of  inheritance  of  congenital  cataracts  [7].
Autosomal dominant congenital cataracts (ADCC) have been
reported to be caused by mutations in 24 different genes to
date: approximately half of the mutations are in the crystallin
genes and a quarter in connexins genes, with the remainder
divided among the genes for heat shock transcription factor-4
(HSF4), aquaporin-0 (AQP0, MIP), paired-like homeodomain
3  (PITX3),  v-maf  musculoaponeurotic  fibrosarcoma
oncogene  homolog  (MAF),  chromatin  modifying  protein
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(CHMP4B),  lens  intrinsic  membrane  protein  2  (LIM2),
beaded  filament  structural  protein-2  (BFSP2)  [5,8],  the
forkhead box protein E3 (FOXE3) [9], Drosophila eyes absent
gene 1 (EYA1) [10], intermediate filament protein vimentin
(VIM) [11], and carboxylic acid transporter family SLC16A12
[12].
According to the location of the lens opacities, and a
detailed  description  of  the  shape  and  appearance,  a
comprehensive approach is to classify the complex spectrum
of  morphological  variations  of  congenital  cataracts.  The
cataract  phenotype  can  be  divided  into  the  following
categories:  total,  nuclear,  cortical,  anterior  subcapsular,
posterior subcapsular, lamellar, cerulean, pulverulent, sutural,
coralliform,  wedge-shaped,  and  polymorphic  cataracts  [5,
13].  Mutations  in  different  genes  may  be  associated  with
similar phenotypes due to genetic heterogeneity [14]. To date,
congenital posterior subcapsular cataracts have been related
to these genes: CRYAB [15,16], CRYBA1 [17], GJA8, receptor
tyrosine  kinase  gene  (EPHA2)  [18],  PITX3  [19],  and
CHMP4B [20].
In  this  paper,  a  four-generation  family  affected  with
congenital posterior subcapsular cataracts was investigated in
an attempt to identify the genetic defect associated with their
cataract phenotype.
METHODS
Clinical evaluation and DNA specimens: The four generation
of the family suffering with ADCC were recruited from the
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144Eye  Center  of  Affiliated  Second  Hospital,  College  of
Medicine, Zhejiang University, Hangzhou, China. Informed
consent in accordance with the Zhejiang Institutional Review
Board  was  obtained  from  all  participants  and  the  study
protocol adhered to the tenets of the Declaration of Helsinki.
In  total,  27  individuals  participated:  nine  affected  and  18
unaffected. Of the 18, nine were spouses (Figure 1A). Also,
100  unrelated  control  subjects  were  recruited.  Detailed
medical  histories  were  obtained  by  interviewing  all
individuals.  All  participants  underwent  ophthalmologic
examinations,  including  visual  acuity  and  slit-lamp
examination with dilated pupils. Five of the affected members
had undergone cataract extraction surgery. Phenotypes were
documented by slit-lamp photography (Figure 1B-D). Blood
samples  were  obtained  by  venipuncture,  collected  in
Vacutainer  tubes  (Becton-Dickinson,  Franklin  Lakes,  NJ)
Figure 1. Clinical features of the family. A: Pedigree of the autosomal dominant congenital cataract. The proband is marked with an arrow.
Squares and circles indicate males and females respectively. Black and white symbols represent affected and unaffected individuals,
respectively. B, C, and D: Slit-lamp photograph of the proband (III:9) shows a posterior subcapsular cataract.
TABLE 1. POLYMERASE CHAIN REACTION PRIMERS AND PRODUCT SIZES OF HUMAN CRYBB2 GENES.
Name Primer sequence (5′-3′) Tm (°C) Product size (bp)
CRYBB22F 5′-CCAGGTCCTCACTGCTGCTTC-3′ 60.34 205
CRYBB22R 5′-CCCATTTTACAGAAGGGCAAC-3′ 58.01
CRYBB23F 5′-ACCCTTCAGCATCCTTTGG-3′ 57.56 314
CRYBB23R 5′-GCAGACAGGAGCAAGGGTAG-3′ 61.9
CRYBB24F 5′-GCTTGGAGTGGAACTGACCTG-3′ 61.92 244
CRYBB24R 5′-GGCAGAGAGAAAGTAGGATGATG-3′ 61.98
CRYBB25F 5′-GCCCCCTCACCCATACTC-3′ 61.86 242
CRYBB25R 5′-CCCCAGAGTCTCAGTTTCCTG-3′ 61.92
CRYBB26F 5′CCTAGTGGCTTATGGATGCTC-3′ 59.97 347
CRYBB26R 5′-TCTTCACTTGGAGGTCTGGAG-3′ 59.97
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145containing EDTA. Leukocyte genomic DNA was extracted
using the QIAmp Blood kit (Qiagen, Duesseldorf, Germany).
Mutation analysis: Genomic DNA samples from affected and
unaffected  members  of  the  family  were  screened  for
mutations in CRYAA, CRYAB, CRYBA1, CRYBB2, CRYGC,
CRYGD,  GJA3,  GJA8,  PITX3,  and  CHMP4B  by  a
combination of direct sequencing and RFLP analysis. The
coding  regions  of  candidate  genes  were  amplified  by
polymerase chain reaction (PCR) using previously published
primer sequences (Table 1) [9,20-26]. The cycling conditions
for PCR were 95 °C preactivation for 5 min, 10 cycles of
touchdown PCR with 0.5 °C down per cycle from 60 °C to
55 °C, followed by 30 cycles with denaturation at 95 °C for
25 s, annealing at 55 °C for 25 s, and extension at 72 °C for
40 s. PCR products were isolated by electrophoresis on 3%
agarose gels and sequenced using the BigDye Terminator
Cycle sequencing kit V 3.1 (ABI Applied Biosystems; Sangon
Co, China) on an ABI PRISM 3730 Sequence Analyzer (ABI),
according  to  the  manufacturer’s  instructions.  Sequencing
results were analyzed using Chromas 1.62 and compared with
sequences  from  NCBI  GenBank  (CRYAA:  21q22.3;
NM_000394, CRYAB: 11q22; NG_009824, CRYBA1: 17q11-
q12;  NM_005208,  CRYBB2:  22q11.2;  NM_000496,
CRYGC:  2q33-q35;  NM_020989,  CRYGD:  2q33-q35;
NM_006891.3,  GJA3:  13q11-q13;  NM_021954,  GJA8:
1q21-q25;  NM_005267,  PITX3:  10q25;  NM_005029,  and
CHMP4B: 20q11.22; NM_176812).
Restriction fragment length polymorphism analysis: Genetic
variations were confirmed by the absence of cleavage sites for
the restriction enzyme HaeIII in affected family members. For
controls,  we  analyzed  100  DNA  samples  from
ophthalmologically normal individuals of the same ethnic
background as the family members. PCR products of exon 2
of the CRYBB2 gene were digested for 10 h at 37 °C with
HaeIII (TAKARA, Dalian, China), then electrophoresized in
5% polyacrylamide gels and analyzed under ultraviolet (UV)
light.
Computational  algorithms:  Computational  methods  have
been shown to be effective in predicting whether a specific
amino acid substitution of a protein sequence is deleterious or
neutral to the function of the protein. Three methods were
used:  Sorting  Intolerant  from  Tolerant  amino  acid
substitutions  (SIFT),  Polymorphism  Phenotyping
(PolyPhen), and Grantham score difference (Align-GVGD).
SIFT  uses  sequence  homology  to  predict  whether  an
amino acid substitution will affect protein function and, thus,
potentially contribute to a disease. It is based on the approach
that important amino acids tend to be highly conserved across
species. SIFT, which assigns scores from 0 to 1, predicts
substitutions with scores less than 0.05 as deleterious, whereas
those  greater  than  or  equal  to  0.05  are  considered  to  be
tolerated [27]. PolyPhen takes into account the evolutionary
conservation of the amino acid subjected to the mutation and
the  physicochemical  characteristics  of  the  wild-type  and
mutated amino acid residue and the consequence of the amino
acid change for the structural properties of the protein [6].
Grantham Variation (GV) measures the degree of biochemical
variation among amino acids found at a given position in the
multiple  sequence  alignment:  Grantham  Deviation  (GD)
reflects the 'biochemical distance' of the mutant amino acid
from the observed amino acid at a particular position (given
by  GV).  Align-GVGD  can  be  used  to  predict  the
transactivation activity of each missense substitution [28]. A
value of GV=0 corresponds to a residue that is invariant in the
alignment, a value of GV of 60–65 is the upper limit of
conservative variation across species, and a value of GV>100
Figure 2. Forward and reverse sequence
analysis of the affected and unaffected
individuals  in  the  ADCC  Chinese
family,  showing  a  heterozygous
mutation  (c.5C>T)  in  exon  2  of
CRYBB2 (black triangles).
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146is  indicative  of  positions  that  are  under  little  functional
constraint.  A  value  of  GD=0  corresponds  to  a  missense
substitution that is within the cross-species range of variation
at its position in the protein; at invariant positions (GV=0);
GD=60–65  is  the  upper  limit  of  a  conservative  missense
substitution [29]. Additionally, for hydropathy analysis we
used Kyte-Doolittle hydropathy plots. All hydropathies for
both  wild-type  and  mutants  were  calculated  in  a  default
window size of 7.
RESULTS
Clinical  evaluation:  The  cataract  exhibited  an  autosomal
dominant inheritance pattern in the family under investigation
(Figure 1A). Opacification of the lens was bilateral in all
affected individuals. There was no family history of other
ocular or systemic abnormalities. Five of the nine patients had
undergone lens surgery. Slit-lamp examination of the eyes in
the  remaining  patients  without  cataract  removal  showed
opacity in the posterior subcapsular region with additional
dot-like opacification in its cortex of bilateral lenses (Figure
1B-D). Visual acuity in the unoperated eyes of those affected
individuals ranged from 0.6 to 0.02. Most affected individuals
noticed their visual impairments in their twenties, and then
their  visual  acuity  decreased  gradually  until  surgery  was
required to improve their visual function after the age of 40.
Mutation screening: Bidirectional sequencing of the coding
regions of the candidate genes showed a heterozygous change,
C>T (Figure 2), at position 5 (c.5C>T) of the CRYBB2 gene
in all nine affected individuals, leading to the replacement of
a highly conserved alanine with valine at the second amino
acid position (p. A2V). This substitution was not seen in the
unaffected individuals or in the 100 unrelated control subjects
(200 chromosomes) from the same Chinese population (data
not shown).
Restriction  fragment  length  polymorphism  analysis:  The
mutation  was  confirmed  by  a  HaeIII  digest  of  the  PCR-
amplified exon 2 of the CRYBB2 gene. This mutation resulted
in the loss a HaeIII restriction site in all the affected members
Figure 3. The CRYBB2 mutation cosegregates with the disease in the family. A: Restriction fragment length analysis (RFLP) showing the loss
of the HaeIII restriction site in heterozygous individuals with the A2V mutation (185 bp) but it was present in unaffected individuals (121 bp
and 64 bp). B: Multiple-sequence alignment in CRYBB2 from different species reveals that codon 2, where the mutation (p. A2V) occurred,
is highly conserved (highlighted in red).
Molecular Vision 2011; 17:144-152 <http://www.molvis.org/molvis/v17/a18> © 2011 Molecular Vision
147of  the  Chinese  family  under  investigation,  but  was  not
detected in the 100 unrelated normal controls or unaffected
pedigree members (Figure 3A).
Multiple-sequence alignment and mutation analysis: Using
the NCBI websites, a multiple sequence alignment showed
that the alanine at position 2 of human the CRYBB2 protein
(Homo sapiens, NP_000487.1) is highly conserved in various
species including Oryctolagus cuniculus (NP_001082786.1),
Bos  taurus  (NP_777232.1),  Macaca  mulatta
(NP_001116366.1),  Canis  lupus  familiaris
(NP_001041578.1),  Cavia  porcellus  (NP_001166542.1),
Mus  musculus  (NP_031799.1),  Xenopus  laevis
(NP_001086491.1), Gallus gallus (NP_990506.2), and Danio
rerio (NP_001018138.1; Figure 3B).
Computational analysis: Computational protein analysis of
A2V  CRYBB2  revealed  the  following  results:  the  SIFT
method revealed a score of 0.00, meaning the substitution is
intolerant.  PolyPhen  analysis  produced  a  score  of  1.603,
which is predicted to be “probably damaging.” Finally, Align-
GVGD showed a score of GV0.00, GD65.28, which belongs
to  class  C65  and  means  “most  likely  to  interfere  with
function.” All of these results indicated the A2V substitution
was likely deleterious and possibly contributed to the disease.
The  Kyte-Doolittle  algorithm  for  hydrophobicity  analysis
showed the local hydrophobicity at and near the altered amino
acid was increased (Figure 4).
DISCUSSION
Crystallins are known to constitute about 90% of the water-
soluble proteins of the lens and contribute to transparency and
refractive properties, due to a uniform concentration gradient
in the lens. The vertebrate crystallins are divided into two
families:  α-crystallins  and  the  β-  and  γ-crystallin  families
[30,31]. The β- and γ-crystallins share a common feature of
anti-parallel β sheets in the proteins, referred to as the “Greek
key motif.” The Greek key motif are agreed to be among the
most stable of structures in proteins. Computer-based analyses
suggest  that  they  form  an  interdomain  association:
intramolecular in the γ-crystallins, and intermolecular in the
β-crystallins. The detailed analysis of the mutations in the β-
and γ-crystallin encoding genes might help to identify those
amino acids which are the important corner stones for this
function [32]. A second functional aspect of the Greek key
motif is its Ca2+ binding properties. A human lens model of
cortical cataract had been developed by Sanderson and his
coworkers  to  study  the  role  of  Ca2+  in  cataractogenesis
[33].Recently, Fischer et al. [34] reported on the effects of β-
and γ-crystallins in axon regeneration of retinal ganglion cells.
The β-crystallin gene consists of six exons; the first exon
is not translated, the second exon encodes the NH2-terminal
extension, and the subsequent four exons are responsible for
one Greek key motif each [35]. Mutations in the CRYBB2 gene
in humans and mice have been reported to induce genetic
cataracts  [8,23,36-49]  (Table  2).  Previously,  nine
geographically distinct families have been reported with the
Figure 4. Hydropathy analysis of  the mutant protein. Kyte-Doolittle hydropathy plot of CRYBB2WT (A) and CRYBB2A2V (B). The x-axis
represents position of amino acids. The y-axis represents the hydropathy value in a default window size of 7. The region of interest is marked
by white boxes. The increase in hydrophobicity in the mutant form is evident.
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148same nonsense mutation (Q155X) in exon 6 of the CRYBB2
gene,  which  is  associated  with  diverse  phenotypes.  This
mutation creates a premature stop codon (Q155X) and results
in an in-frame stop codon at nucleotide 475 of exon 6 that may
cause a truncation of 50 amino acids from the COOH-terminus
of βB2-crystallin, which destabilizes the domain structure of
betaB2-crystallin.  Using  a  mammalian  two-hybrid  system
assay, spectroscopy (circular dichroism and fluorescence) and
fast performance liquid chromatography (FPLC), the Q155X
mutant  shows  not  only  decreased  ordered  structure  and
stability, but also a decrease in protein–protein interactions
with  βB2-crystallin  mutant,  which  might  contribute  to
cataract formation [50]. This mutation is explained by a gene
conversion mechanism between the CRYBB2 gene and its
pseudogene CRYBB2P1. The diversity of the phenotypes may
be  caused  by  variations  in  the  promoter  region,  possibly
influencing the expression of the CRYBB2 protein in the lens
or other crystallin genes as modifiers from surrounding loci
[37,39]. The other mutations were found in exons 3, 5, and 6.
A2V  in  the  CRYBB2  gene  characterized  here  is  the  first
reported mutation in exon 2 (NH2-terminal extension) of the
CRYBB2 gene.
βB2-crystallin, the major component of β-crystallin, is a
homodimer at low concentrations, and can form a heterodimer
with other beta-crystallins under physiologic conditions [51].
Based  on  the  structure  from  X-ray  refraction  studies  for
homodimer  βB2-crystallin,  each  subunit  includes  16  β-
strands, eight in the NH2-terminal domain and eight in the
COOH-terminal  domain  [51].  The  results  of  NMR
spectroscopic studies indicate that the terminal extensions of
beta B2-crystallin appear to be of little ordered conformation,
are accessible to solvent and flex freely from the main body
of the protein [52].Earlier studies indicated that the NH2-
terminal extension of β-crystallin played an important role in
oligomerization [53].Recent experimental data suggest that
the NH2- and COOH-terminal arms appear to be involved in
preventing  the  formation  of  higher  homo-  and  hetero
oligomers [54].The long and flexible NH2-terminal extension
of the CRYBB2 (PDB structure 1YTQ) might be critical for
mediating protein interactions. Thus, the A2V substitution
may influence homo- and heteromolecular interactions, which
would  contribute  to  cataract  formation.  In  addition,  lens
crystallins are known to be susceptible to a wide variety of
post-translational  modifications  such  as  acetylation,
deamidation,  methylation,  oxidation,  phosphorylation,  and
truncation of terminal extensions by thiol proteases. Age-
related  proteolytic  processing  of  human  lens  β-crystallins
occurs mainly at the NH2-terminal extensions [55]. This single
base  substitution  may  play  a  role  in  post-translational
modifications  of  crystallins,  which  would  lead  to  protein
structure and function alteration.
By the SIFT, PolyPhen, and Align-GVGD programs, we
evaluated the possible effect of this amino acid substitution
(p. A2V) on βB2-crystallin protein function. The programs
TABLE 2. PREVIOUS CRYBB2 GENE MUTATIONS ASSOCIATED WITH CONGENITAL CATARACTS.




c. G607A p. V187M Nuclear cataract Basotho [36]
c. C475T p. Q155X Sutural opacity and fish tail-like
branches
American [37]
c. C475T p. Q155X Cerulean American [8]
c. C475T p. Q155X ADCC Canadian [38]
c. C475T p. Q155X ADCC Chilean [39]
c. C475T p. Q155X Progressive polymorphic
coronary ADCC
Indian [40]
c. C92T p. S31W Coronary cataract Chinese [41]
c. C475T p. Q155X Cerulean ADCC Chinese [42]
c. C475T p. Q155X Progressive polymorphic Chinese [43]
c. G465T p. W151C Central nuclear Indian [44]
c. A383T p. D128V Dominant ring-shaped cortical
cataract
Germany [45]
c.C489A p. Y159X ADCC Danish [46]
c.C433T p. R145W ADCC Danish [46]
c.A440G p. Q147R ADCC Danish [46]
c.C449T p. T150M ADCC Danish [46]
Mouse mutations
Intron 5:_57 A->T Splicing: 19 new amino acids in front
of exon 6
Progressive cataract [47]
c. T560A p. V187Q Progressive cataract [35]
585–587 Deletion 195–198 ΔQSVR Progressive cataract [48,49]
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149were  used  to  determine  whether  a  specific  amino  acid
substitution would lead to an altered protein structure and
function,  based  on  sequence  homology  and  structural
information.  As  the  isolated  predictive  value  of  these
programs can be increased by their combination [6,56], it is
believed that the A2V mutation alters the protein structure of
the βB2-crystallin protein to such an extent it may contribute
to the disease.
Also,  hydropathy  analysis  revealed  a  variation  in  the
physicochemical properties of the critical region in the A2V
mutant (Figure 4B) compared with wild-type βB2-crystallin
(Figure 4A). The environment surrounding the amino acid
“V” in the mutant protein is more hydrophobic. Thus, the
increase in hydrophobicity in the mutant form might affect the
solubility  of  the  mutant  protein  and  hence  contribute  to
cataract formation.
Conclusions: A novel A2V mutation of the CRYBB2
protein was identified and characterized in a Chinese family
presenting with the posterior subcapsular type of congenital
cataract. Further experiments on this cataract-related genetic
defect and the factors that modify their variable phenotypes
will improve our understanding of the mechanism of cataract
formation  and  illuminate  the  developmental  biology  and
biochemistry of the lens.
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